http://www.immunologyproductguide.com/blog A comprehensive guide to immunology products for medical professionals Fri, 11 Jun 2010 10:09:04 +0000 http://wordpress.org/?v=2.8.2 en hourly 1 http://www.immunologyproductguide.com/blog/2008/10/10/fda-approves-reyataz-capsules-for-treating-hiv-1-infection/ http://www.immunologyproductguide.com/blog/2008/10/10/fda-approves-reyataz-capsules-for-treating-hiv-1-infection/#comments Fri, 10 Oct 2008 10:34:51 +0000 Jim Marino http://www.immunologyproductguide.com/blog/2008/10/10/fda-approves-reyataz-capsules-for-treating-hiv-1-infection/ Bristol-Myers Squibb Co.’s Reyataz (atazanavir) capsule (300 mg) has been approved by the U.S. Food and Drug Administration for use in combination with ritonavir (100 mg) to treat HIV-1 infection. On the basis of results of the year-long trial which show that atazanavir was as effective as lopinavir along with ritonavir in achieving virologic response  in adult patients who received tenofovir and emtricitabine (300 mg/200 mg once daily) therapy simultaneously.

]]> http://www.immunologyproductguide.com/blog/2008/10/10/fda-approves-reyataz-capsules-for-treating-hiv-1-infection/feed/ 0